Investing.com - Financial Markets Worldwide

Sansure Biotech Inc (688289)

Shanghai
Currency in CNY
22.18
-0.16(-0.72%)
Closed·
688289 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688289 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
22.0622.47
52 wk Range
16.4426.36
Key Statistics
Edit
Bid/Ask
22.17 / 22.18
Prev. Close
22.34
Open
22.31
Day's Range
22.06-22.47
52 wk Range
16.44-26.36
Volume
6.73M
Average Volume (3m)
5.65M
1-Year Change
20.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688289 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Buy
Analysts Sentiment
Strong Buy
Price Target
24.45
Upside
+10.23%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Analysts anticipate sales growth in the current year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Sansure Biotech Inc Company Profile

Sansure Biotech Inc. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments in China. It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tract infections; nucleic acid tests and fluorescence diagnostic kits for blood-borne infections; RNA diagnostic kits for gastrointestinal infections; and diagnostic kits for monkeypox, epstein-barr virus, and human cytomegalovirus DNA, as well as rapid antigen tests. The company provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems. In addition, it engages in the research and development, production, and sale of drugs; procurement and sale of raw materials; manufacture of instruments; manufacture and sale of electronic equipment; trading; investment advisory; medical research and experimental development; and internet sales, as well as offers third-party medical testing and biotechnology development services. The company was founded in 2008 and is headquartered in Changsha, China.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
2346
Market
China

Compare 688289 to Peers and Sector

Metrics to compare
688289
Peers
Sector
Relationship
P/E Ratio
44.8x25.2x−0.5x
PEG Ratio
−1.720.620.00
Price/Book
1.7x2.3x2.6x
Price / LTM Sales
8.3x7.3x3.3x
Upside (Analyst Target)
9.4%24.8%42.8%
Fair Value Upside
Unlock21.2%6.5%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 24.45
(+10.23% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.49%
Dividend Yield
2.35%
Industry Median 1.85%
Annualised payout
0.53
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.16 / --
Revenue / Forecast
475.49M / --
EPS Revisions
a
a
Unlock
Last 90 days

688289 Income Statement

FAQ

What Stock Exchange Does Sansure Biotech Trade On?

Sansure Biotech is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Sansure Biotech?

The stock symbol for Sansure Biotech is "688289."

What Is the Sansure Biotech Market Cap?

As of today, Sansure Biotech market cap is 12.83B.

What Is Sansure Biotech's Earnings Per Share (TTM)?

The Sansure Biotech EPS (TTM) is 0.49.

When Is the Next Sansure Biotech Earnings Date?

Sansure Biotech will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is 688289 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Sansure Biotech Stock Split?

Sansure Biotech has split 1 times.

How Many Employees Does Sansure Biotech Have?

Sansure Biotech has 2346 employees.

What is the current trading status of Sansure Biotech (688289)?

As of 06 Aug 2025, Sansure Biotech (688289) is trading at a price of 22.18, with a previous close of 22.34. The stock has fluctuated within a day range of 22.06 to 22.47, while its 52-week range spans from 16.44 to 26.36.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.